New Delhi, Dec 3 (IANS) Young innovators from across the country presented their innovative solutions for energy storage and sustainability during the SheSTEM 2024 -- an annual event by Atal Innovation Mission (AIM), and the Office of…

Seoul, Dec 3 (IANS) South Korea's presidential committee on population policy on Tuesday unveiled plans to have up to 70 per cent of fathers take parental leave by 2030 as the government intensifies efforts to tackle the nation's pressing…

Bengaluru, Dec 3 (IANS) HealthCare Global Enterprises (HCG) on Tuesday announced a partnership with Accenture to accelerate cancer research and care through advanced AI, including generative AI and deep learning. The collaboration will…

New Delhi, Dec 3 (IANS) A common heart drug has shown promise to delay the onset of Huntington's disease -- a progressive and inherited brain disorder that causes nerve cells in the brain to break down, according to a new study. Common…

New Delhi, Dec 3 (IANS) A team of US scientists has deemed two commonly used antiseizure medications -- lamotrigine and levetiracetam -- safe to use during pregnancy. Epilepsy -- a chronic neurological condition -- is characterised by…

Seoul, Dec 3 (IANS) South Korea's antitrust regulator on Tuesday said it has fined leading drugmaker Celltrion 435 million won ($309,900) for engaging in unfair business practices. The biopharmaceutical giant is accused of unfairly…

New Delhi, Dec 2 (IANS) In a bid to enable cities to become "self-reliant" and "water secure", central assistance of Rs 66,750 crore has been allocated for the projects under the Atal Mission for Rejuvenation and Urban Transformation…

New Delhi, Dec 2 (IANS) US researchers have, in a study on Monday, found a link between hidden belly fat, known as visceral fat, and abnormal proteins in the brain -- hallmarks of Alzheimer’s disease. Visceral fat refers to the accumulation…

New Delhi, Dec 2 (IANS) Eating more plant-based protein than animal-based protein may help reduce the risk of cardiovascular disease (CVD) and coronary heart disease (CHD), according to a new study on Monday. The study, led by researchers…

New Delhi, Dec 2 (IANS) Four oral glucagon-like peptide-1 receptor (GLP1R) drugs, currently under Phase III trials, are in the race for approval, according to a report. This follows the immense popularity of injectible GLP1R drugs, such as…